Sharmila Shankar - Concepedia

Author

Sharmila Shankar

University of Kansas Medical Center ORCID

Also Known As

Rashmi Srivastava, S SHANKAR, S Shankar, S. Gobi Shankar, S. Shankar, Shankar S., Shankar, Sharmila, Sharmila Shankar, Sharmila Shankar (35354), Yiming Ma

146

Publications

11.1K

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center The University of Kansas Cancer Center Kansas City VA Medical Center The University of Texas Health Science Center at Tyler University of Maryland, Baltimore

About

Sharmila Shankar is an author at University of Kansas Medical Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	36	4K
2	Health Sciences	5	5	555
3	Engineering	3	3	225
4	Natural Sciences	2	2	138
5	Social Sciences	1	1	215

Sharmila Shankar

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer Sanjit K. Roy, Sharmila Shankar Journal of Molecular Signaling	2010	368
Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition Sharmila Shankar, Dara Nall, Su‐Ni Tang, PLoS ONE	2011	300
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer Sharmila Shankar Frontiers in bioscience Chemoprevention StrategyPathologyCell DeathCancer BiologyTumor Biology	2007	268
Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells Dara Nalls, Su‐Ni Tang, Marianna Rodova, PLoS ONE	2011	259
Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Thiyam Ramsing Singh, Sharmila Shankar, Xufen Chen, PubMed Breast OncologySynergistic InteractionsMedicineApoptosisCell Death	2003	247
Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer Sharmila Shankar International Journal of Oncology Mitochondrial P53OncologyChemoprevention StrategyOncogenic AgentMedicine	2007	235
The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition Su‐Ni Tang, Chandan Singh, Dara Nall, Journal of Molecular Signaling	2010	219
Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway Dhruv Kumar, Sharmila Shankar Cancer Letters Cell AutophagyMitophagyRottlerin InducesSignaling PathwayCell Regulation	2013	219
Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory Pavan Srivastava, Prabhash Nath Tripathi, Piyoosh Sharma, European Journal of Medicinal Chemistry Alzheimer's DiseaseBiochemistryMedicinePhenyl Benzoxazole DerivativesPotent Acetylcholinesterase Inhibitor	2018	215
Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells Brahma N. Singh, Dhruv Kumar, Sharmila Shankar Biochemical Pharmacology Cell AutophagyRottlerin InducesPancreatic CancerCell RegulationCell Signaling	2012	213

Page 1